Some patients at our Doral clinic combine it with our NAD+ Treatment Plan at Perfect B to support cellular energy production during the repair cycle
The Risk of Research Peptides Like DSIP Most people come across DSIP through: Peptide websites Research use only suppliers Forums and social media That creates real risks: No regulation or quality control Unknown purity and dosing No safety oversight No long-term human data Even though DSIP is not an opioid, using unregulated compounds during recovery can still: Disrupt progress Create new dependencies on routines or substances Mask underlying issues without treating them Why People in Recovery Are Drawn to It This part matters
Following standard protocols and cycling your use prevents this concern
Deficiency symptoms include pale skin, headaches, shortness of breath, digestive-related issues, and mood changes
That means every vial you receive meets the same exacting standard giving you data you can trust, study after study
With both compounds reducing energy intake (tirzepatide through appetite) and mobilizing stored energy (AOD 9604 through lipolysis), the body is working harder to maintain homeostasis